Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 266

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 10
Chunk 266
---
 in lieu of expired previous orders from 2023.
 
Information on that transaction is set forth in this Annual Report under “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources— Casterra Agreement with ENI” and is incorporated by reference herein.
 
Lavie Bio Licensing Agreement for Bio-Fungicides with Corteva Agriscience
 
On July 14, 2023, Lavie Bio entered into a licensing agreement with Corteva Inc. This agreement grants Corteva perpetual, exclusive rights (subject to reaching certain commercial milestones) to further develop and commercialize the lead bio-fungicide candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.
 
In November 2024 Lavie Bio received notice of termination of this agreement. Pursuant to the terms of the agreement, Lavie Bio received an initial payment of $ 5.0 million from Corteva, which will not be repaid to Corteva because of the termination. Lavie Bio has regained all rights to the licensed technology and the lead bio-fungicide candidates.
 
Information on that transaction is set forth in this Annual Report under “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources— Lavie Bio Licensing Agreement for Bio-Fungicides with Corteva Agriscience” and is incorporated by reference herein.
 

Indemnification Agreements
 
We have entered into indemnification agreements with our office holders. Information on the indemnification agreements may be found in this Annual Report under “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Agreements with Directors and Officers—Indemnification Agreements,” and is incorporated herein by reference.
Other Compensation Agreements
 

◾   Evogene Ltd. Officers Compensation Policy. See “Item 6. Directors, Senior Management and Employees” for more information
                                                      about this document.                                                  
----------------------------------------------------------------------------------------------------------------------------

◾   Evogene Ltd. Officers Clawback Policy. See “Item 6. Directors, Senior Management and Employees” for more information
                                                    about this document.                                                
------------------------------------------------------------------------------------------------------------------------

◾   Evogene Ltd. 2013 Share Option Plan. See “Item 6. Directors, Senior Management and Employees” for more information about
                                                         this document.                                                     
----------------------------------------------------------------------------------------------------------------------------

◾   Evogene 2021 Share Incentive Plan. See “Item 6. Directors, Senior Management and Employees